Creo Medical (GB:CREO) has released an update.
Creo Medical Group PLC has announced the successful completion of its Retail Offer, resulting in the issuance of 369,109 shares at 24 pence each. These new shares, along with an additional 50 million Placing Shares, will be traded on the AIM market of the London Stock Exchange starting October 21, 2024, pending shareholder approval. This move highlights Creo’s commitment to expanding its innovative electrosurgical medical device portfolio.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.
